Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis

被引:2
|
作者
Perez-Ruixo, Juan-Jose [1 ]
Zhu, Yaowei [1 ]
Neyens, Martine [1 ]
Jouvin, Marie-Helene [1 ]
Ramchandren, Sindhu [1 ]
Xu, Yan [1 ]
Leu, Jocelyn [1 ]
Dosne, Anne-Gaelle [1 ]
Xiong, Yuan [1 ]
Valenzuela, Belen [1 ]
Ling, Leona [1 ]
Nandy, Partha [1 ]
Sun, Hong [1 ]
机构
[1] Janssen Res & Dev, Raritan, NJ USA
关键词
D O I
10.1212/WNL.0000000000203877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1-5.018
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis
    Antozzi, Carlo
    Guptill, Jeffrey
    Bril, Vera
    Gamez, Josep
    Meuth, Sven G.
    Nowak, Richard J.
    Quan, Dianna
    Sevilla, Teresa
    Jouvin, Marie-Helene
    Jin, Jim
    Karcher, Keith
    Ramchandren, Sindhu
    Sun, Hong
    Ling, Leona
    Zhu, Yaowei
    Arroyo, Santiago
    NEUROLOGY, 2024, 102 (02)
  • [2] VIVACITY MG PHASE 3 STUDY: CLINICAL TRIAL OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
    Ramchandren, Sindhu
    Sanga, Panna
    Burcklen, Michel
    Sun, Hong
    MUSCLE & NERVE, 2022, 66 : S51 - S51
  • [3] Vivacity MG Phase 3 Study: Clinical Trial of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
    Ramchandren, Sindhu
    Sanga, Panna
    Burcklen, Michel
    Sun, Hong
    NEUROLOGY, 2022, 99 (23) : S41 - S41
  • [4] Vivacity MG Phase 3 Study: Clinical Trial of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
    Ramchandren, S.
    Sanga, P.
    Burcklen, M.
    Sun, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 299 - 299
  • [5] SYMPTOM SEVERITY ASSESSMENT USING MGADL ITEMS AND DOMAINS IN A 24-WEEK, PHASE 3 STUDY (VIVACITY) OF NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS.
    Farmakidis, Constantine
    Gandhi, Kavita
    Ait-Tihyaty, Maria
    Turkoz, Ibrahim
    Pease, Sheryl
    Choudhry, Zia
    Gary, Charlotte
    El Khoury, Antoine
    Ramchandren, Sindhu
    MUSCLE & NERVE, 2024, 70 (03) : 712 - 713
  • [6] Response to rozanolixizumab in patients with generalized myasthenia gravis (gMG) from the Phase 3 MycarinG study
    Vissing, J.
    Druzdz, A.
    Grosskreutz, J.
    Habib, A.
    Mantegazza, R.
    Utsugisawa, K.
    Vu, T.
    Grimson, F.
    Lejdstrom, R. Beau
    Pulido-Valdeolivas, I.
    Tarancon, T.
    Bril, V.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S178 - S179
  • [7] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: phase 3 adapt study results
    Mantegazza, R.
    Bril, V.
    Vu, T.
    Karam, C.
    Peric, S.
    Margania, T.
    Murai, H.
    Biliska, M.
    Shakarishvili, R.
    Smilowski, M.
    Guglietta, A.
    Ulrichts, P.
    Vangeneugden, T.
    Utsugisawa, K.
    Verschuuren, J.
    Howard, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 80 - 80
  • [8] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results
    Mantegazza, Renato
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Howard, James
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [9] Development of generalized myasthenia gravis in patients with ocular myasthenia gravis
    Papapetropoulos, TH
    Ellul, J
    Tsibri, E
    ARCHIVES OF NEUROLOGY, 2003, 60 (10) : 1491 - 1492
  • [10] EFFICACY AND SAFETY OF NIPOCALIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: TOPLINE RESULTS FROM THE DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 3 VIVACITY-MG3 STUDY
    Vu, Tuan
    Antozzi, Carlo
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    Youssef, Eriene
    Sanga, Panna
    Karcher, Keith
    Zhu, Yaowei
    Ling, Leona
    Sun, Hong
    MUSCLE & NERVE, 2024, 70 (03) : 655 - 655